Daniel Skovronsky - 23 Jun 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Jun 2026, 16:25:15 UTC
Prior SEC filing
23 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Justin Hunter For: Daniel Skovronsky

Key filing fact

Daniel Skovronsky filed Form 4 for MYRIAD GENETICS INC (MYGN) on 23 Jun 2026.

Key facts

  • This page summarizes Daniel Skovronsky's Form 4 filing for MYRIAD GENETICS INC (MYGN).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Jun 2026, 16:25.

Change

  • Previous filing in this sequence was filed on 23 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001741474 Primary reporting owner

Skovronsky Daniel

Relationship
Director
Address
322 NORTH 2200 WEST, SALT LAKE CITY
Signature
By: Justin Hunter For: Daniel Skovronsky
Signature date
23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
195,507
Date
23 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Daniel Skovronsky is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a director of the Company, effective June 17, 2026, and therefore is no longer subject to Section 16 reporting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .